MACS PICK UP POINT Technology
Natural Killer Cells: Cultivation, Activation and Growth
Miltenyi Biotec extends its product portfolio in the area of cell culture media with the NK MACS® Medium
Miltenyi Biotec named as an employer for the future
In its current issue, the news magazine “Focus” has published the results of a survey with the title “Germany’s best jobs with a future“.
New: MACSprep™ PBMC Isolation Kit, human from Miltenyi Biotec
Fast and convenient isolation of untouched PBMCs
New: MACS® GMP T Cell TransAct™ from Miltenyi Biotec
MACS® GMP T Cell TransAct™ is a ready-to-use reagent for efficient in vitro activation and expansion of human T cells. Also available in research grade.
The EU project CARAT has taken on the mission to deliver new tools and technologies to enable the wide use of novel personalized cancer treatment options. In 2017, CARAT will grant five scientists with a fellowship that gives them the opportunity to participate in a unique training.
Miltenyi Biotec introduces the largest portfolio of recombinant antibodies optimized for flow cytometry – REAfinity™ Antibodies
Once again, the MACS® Academy is offering a comprehensive course program at its locations in Bergisch Gladbach, Germany and San Diego, USA, in 2017 - miltenyibiotec.com/macsacademy.November 22, 2016
Genethon, a leader in the field of gene therapy treatments for rare diseases, and Miltenyi Biotec, a global front-runner in cell processing and related technologies in cell therapy, have announced the execution of an exclusive license to the patents and trademarks for the development and commercialization of Vectofusin-1® by Miltenyi Biotec.September 29, 2016
Miltenyi Biotec has expanded its assortment of antibodies with a series of CE marked in vitro-diagnostic medical devices – MACS® IVD Antibodies. They can be used in both clinical flow cytometry and in the quality control of cellular products for translational research.September 19, 2016
Register for account